Qiagen (Pecura business) Overview
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Financing Rounds
- 1
Qiagen (Pecura business) General Information
Description
Provider of veterinary products distribution services. The company's services include holding of veterinary license for the immunstimulatory cytosine-phosphodiester-guanine (CpG) dinucleotides, presented in synthetic oligodeoxynucleotides (CpG-ODN), which are believed to have promising potential in veterinary applications for livestock and companion animals.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- Venlo
- Netherlands
Qiagen (Pecura business) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Qiagen (Pecura business)‘s full profile, request access.
Request a free trialQiagen (Pecura business) Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Rolf Hecker | Director |
Qiagen (Pecura business) Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Qiagen (Pecura business)‘s full profile, request access.
Request a free trial